ATE527342T1 - Zellkultur mit nm23, nm23 umfassende zellkulturmedien sowie therapeutische verwendung von in gegenwart von nm23 kultivierten zellen - Google Patents

Zellkultur mit nm23, nm23 umfassende zellkulturmedien sowie therapeutische verwendung von in gegenwart von nm23 kultivierten zellen

Info

Publication number
ATE527342T1
ATE527342T1 AT04798545T AT04798545T ATE527342T1 AT E527342 T1 ATE527342 T1 AT E527342T1 AT 04798545 T AT04798545 T AT 04798545T AT 04798545 T AT04798545 T AT 04798545T AT E527342 T1 ATE527342 T1 AT E527342T1
Authority
AT
Austria
Prior art keywords
cell culture
cells
therapeutic use
cells cultured
biological cells
Prior art date
Application number
AT04798545T
Other languages
English (en)
Inventor
Christopher Martin Bunce
Original Assignee
Univ Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29764656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE527342(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Birmingham filed Critical Univ Birmingham
Application granted granted Critical
Publication of ATE527342T1 publication Critical patent/ATE527342T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04798545T 2003-12-05 2004-11-16 Zellkultur mit nm23, nm23 umfassende zellkulturmedien sowie therapeutische verwendung von in gegenwart von nm23 kultivierten zellen ATE527342T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0328245A GB0328245D0 (en) 2003-12-05 2003-12-05 Therapeutic use of biological cells
PCT/GB2004/004826 WO2005056780A2 (en) 2003-12-05 2004-11-16 Cell culture with nm23, cell culture media comprising nm23 and therapeutic use of cells cultured in the presence of nm23.

Publications (1)

Publication Number Publication Date
ATE527342T1 true ATE527342T1 (de) 2011-10-15

Family

ID=29764656

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04798545T ATE527342T1 (de) 2003-12-05 2004-11-16 Zellkultur mit nm23, nm23 umfassende zellkulturmedien sowie therapeutische verwendung von in gegenwart von nm23 kultivierten zellen

Country Status (7)

Country Link
US (1) US8802434B2 (de)
EP (1) EP1697503B1 (de)
CN (1) CN1926234B (de)
AT (1) ATE527342T1 (de)
CA (1) CA2548157A1 (de)
GB (1) GB0328245D0 (de)
WO (1) WO2005056780A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0328245D0 (en) 2003-12-05 2004-01-07 Univ Birmingham Therapeutic use of biological cells
CN101652469B (zh) * 2006-12-06 2014-04-16 米纳瓦生物技术公司 用于鉴定和操作细胞的方法
KR20160017117A (ko) * 2008-10-09 2016-02-15 미네르바 바이오테크놀로지 코포레이션 세포내에서 다능성을 유도하기 위한 방법
EP2625267A2 (de) 2010-10-06 2013-08-14 Omnicyte Ltd. Kulturverfahren zur kultivierung pluripotenter zellen mit einem mirna-181a*-inhibitor
WO2012126013A2 (en) 2011-03-17 2012-09-20 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
CA2852244C (en) * 2011-10-17 2023-10-17 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
KR100450578B1 (ko) * 2002-03-05 2004-09-30 주식회사 안지오랩 엔엠23 단백질을 유효성분으로 하는, 매트릭스메탈로프로테아제 활성 억제 및 혈관신생 억제용 조성물
GB0328245D0 (en) 2003-12-05 2004-01-07 Univ Birmingham Therapeutic use of biological cells

Also Published As

Publication number Publication date
EP1697503B1 (de) 2011-10-05
GB0328245D0 (en) 2004-01-07
EP1697503A2 (de) 2006-09-06
WO2005056780A8 (en) 2006-10-05
CN1926234B (zh) 2011-10-12
CA2548157A1 (en) 2005-06-23
US8802434B2 (en) 2014-08-12
WO2005056780A2 (en) 2005-06-23
CN1926234A (zh) 2007-03-07
US20070243171A1 (en) 2007-10-18
WO2005056780A3 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
Salinas et al. Shear stress induced by fluid flow produces improvements in tissue-engineered cartilage
AU2009240884A8 (en) Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
ATE531383T1 (de) Therapeutische verwendung eines wachstumsfaktors, metrnl
GB2434157A (en) Platelets from stem cells
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
MXPA05006350A (es) Composicion de medio de cultivo, procedimiento de cultivo y mioblastos obtenidos y sus utilizaciones.
AU2003304250A1 (en) Method of isolating cells from umbilical cord
MX2010000393A (es) Metodo para el aislamiento y cultivo de celulas madre adultas derivadas del epitelio amniotico humano.
BR112014003708A2 (pt) microorganismos métodos para a produção de 2,4-pentadienoato, butadieno, propileno, 1,3-butanodiol e álcoois relacionados
NZ593365A (en) Pharmaceutical preparation comprising a blood mononuclear cell culture
ATE426016T1 (de) Pluripotent embryonale stammzellen-ahnliche zellen, zusammensetzungen und ihre vervendungen
US9663761B2 (en) Use of annelid haemoglobin for maintaining stem cells in the undifferentiated state
CA2543118A1 (en) Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease
ATE527342T1 (de) Zellkultur mit nm23, nm23 umfassende zellkulturmedien sowie therapeutische verwendung von in gegenwart von nm23 kultivierten zellen
ABDEL‐NASER Differential effects on melanocyte growth and melanization of low vs. high calcium keratinocyte‐conditioned medium
ATE400654T1 (de) Neues säugetiergen bc1-w, welches zur bc1-2 familie apoptose-kontrollierender gene gehört
WO2006045105A3 (en) Generation and differentiation of adult stem cell lines
BRPI0610968A2 (pt) composição de sangue de cordão umbilical, e, métodos para tratar uma doença maligna ou distúrbio benigno associado com o sistema hemoatopoiético e para preparar uma composição de sangue umbilical
ATE544849T1 (de) Aktivierte dendritische zellen, therapieverfahren unter verwendung der dendritischen zellen sowie verfahren zur kultivierung von gamma-delta-t- zellen
MX336067B (es) Celula madre para uso terapeutico, la cual se deriva de monocito humano y metodo para inducir la misma.
WO2005054447A3 (en) Müller stem cells
NO20060637L (no) Autologe selv-toleranse induserende celler av monocytisk opprinnelse og deres anvendelse i farmasoytiske preparater
AU8478601A (en) Methods for culturing human lung mast cells and uses thereof
WO2009019758A1 (ja) 腎臓幹／前駆細胞の分離方法及び腎臓幹／前駆細胞、並びに腎疾患治療剤
WO2006065272A3 (en) Methods for altering acetic acid production and enhancing cell death in bacteria

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties